Supporting patients after disclosure of abnormal first trimester screening results

Current Opinion in Obstetrics and Gynecology

Volumn 24, Issue 2, 2012, Pages 109-113

  Fisher, Jane ^a  

^a Antenatal Results and Choices (ARC)   (United Kingdom)

Author keywords

Aneuploidy; Communicating results; Down's syndrome; Fetal anomaly abnormality; Maternal anxiety; Prenatal screening; Psychological impact

Indexed keywords

ABNORMAL LABORATORY RESULT; CONFLICT; DOWN SYNDROME; FATHER; FIRST TRIMESTER PREGNANCY; HUMAN; INFORMATION DISSEMINATION; INFORMED CONSENT; KNOWLEDGE; MEDICAL ETHICS; PATIENT COUNSELING; PATIENT DECISION MAKING; PREGNANCY OUTCOME; PRENATAL SCREENING; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; REVIEW;

ANEUPLOIDY; DISCLOSURE; FATHERS; FEMALE; GENETIC COUNSELING; HUMANS; MALE; MOTHERS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; TIME FACTORS;

EID: 84859782204     PISSN: 1040872X     EISSN: 1473656X     Source Type: Journal    
DOI: 10.1097/GCO.0b013e3283505b4f     Document Type: Review

References (23)

1. Malone FD, Canick JA, Ball RH, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005; 353:19.
2. Nicolaides K. A model for a new pyramid of prenatal care based on the 11-13 weeks assessment. Prenat Diag 2011; 31:3-6. Nicolaides gives an eloquent exposition of the clinical benefits of comprehensive first trimester screening. It should be noted that within the UK NHS setting in which he works, a psychotherapeutic support service is in place for parents given difficult news.
3. Farrell RM, Dolgin N, Flocke SA, et al. Risk and uncertainty: Shifting decision making for aneuploidy screening to the first trimester of pregnancy. Genet Med 2011; 13:429-436. This study explores the challenge first trimester screening presents to facilitating informed decision-making.
4. Dahl K, Hvidman L, Jørgensen FS, Kesmodel US. Knowledge of prenatal screening and psychological management of test decisions. Ultrasound Obstet Gynecol 2011; 38:152-157.
5. Seror V, Ville Y. Women's attitudes to the successive decisions possibly involved in prenatal screening for Down syndrome: How consistent with their actual decisions? Prenat Diagn 2010; 30:1086-1093.
6. Tsouroufli M. Routinisation and constraints on informed choice in a one-stop clinic offering first trimester chromosomal antenatal screening for Down's syndrome. Midwifery 2011; 27:431-4367.
7. Moonlight K. North East Regional Update in NHS Fetal anomaly Programme Progress Update 12 (2009). http://www.screening.nhs.uk/northeast. [Accessed 5 September 2011].
8. Tringham GM, Nawaz TS, Holding S, et al. Introduction of first trimester combined test increases uptake of Down's syndrome screening. Eur J Obstet Gynecol Reprod Biol 2011; 159:95-98.
9. Pandya PP, Snijders RJM, Johnson SP, et al., Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. BJOG Int J Obstetrics Gynaecol 1995; 102:957-962. doi: 10.1111/j.1471-0528.1995.tb10902.x (Pubitemid 26014990)
10. McCoyd JL. Authoritative knowledge, the technological imperative and women's responses to prenatal diagnostic technologies. Cult Med Psychiatry 2010; 34:590-614; PubMed PMID: 20835757.
11. Weinans MJN, Kooij L, Muller MA, et al. Comparison of the impact of screenpositive results obtained from ultrasound and biochemical screening for Down syndrome in the first trimester: A pilot study. Prenat Diagn 2004; 24:347-351. (Pubitemid 38724858)
12. Georgsson O ̈hman S, Saltvedt S, Waldenström U, et al. Pregnant women's responses to information about an increased risk of carrying a baby with Down's syndrome. Birth 2006; 33:64-73. (Pubitemid 44366948)
13. Bilardo C, Timmerman E, Pajkrt E, van Maarle M. Increased nuchal translucency in euploid fetuses: What should we be telling the parents? Prenat Diagn 2010; 30:93-102. This study gives a useful clinical overview of the possible implications of a raised nuchal translucency measurement and helps clinicians reflect on how difficult this can be to deal with for parents.
14. Chelemen T, Syngelaki A, Maiz N, et al. Contribution of ductus venosus doppler in first-trimester screening for major cardiac defects. Fetal Diagn Ther 2011; 29:127-134.
15. Nicolaides K. Screening for fetal aneuploidies at 11-13 weeks. Prenat Diagn 2011; 31:7-15.
16. Fisher J. First-trimester screening: Dealing with the fall-out. Prenat Diagn 2011; 31:46-49.
17. de Jong A, Dondorp WJ, Frints SGM, et al. Advances in prenatal screening: The ethical dimension. Nat Rev Genet 2011; 12:657-663.
18. Williams C. Dilemmas in fetal medicine: Premature application of technology or responding to women's choicě Sociol Health Illness 2006; 28:1-20. (Pubitemid 43332398)
19. Kleinveld JH, Ten Kate LP, van den Berg M, et al. Does informed decisionmaking influence psychological outcomes after receiving a positive screening outcomě Prenat Diagn 2009; 29:271-273; doi:10.1002/pd.2186.
20. Bryant, LD, Ahmed, S, Hewison J. Conveying information about screening. In: Rodeck C, Whittle M, editors. Fetal Medicine: Basic Science and Clinical Practice Second. Edinburgh: Elsevier, 2008; pp. 225-233.
21. Heyman B, Hundt G, Sandall J, et al. On being at higher risk: A qualitative study of prenatal screening for chromosomal abnormalities. Soc Sci Med 2006; 62:2360-2372.
22. Reid B, Sinclair M, Barr O, et al., Meta-synthesis of pregnant women's decision-making processes with regard to antenatal screening for Down syndrome. Soc Sci Med 2005; 69:1561-1573.
23. Ahman A, Lindren P. Sarkadi A., Facts first, then reaction: Expectant fathers' experiences of an ultrasound screening identifying softmarkers. Midwifery 2011. [Epub ahead of print]